Neurophet

At a glance

Neurophet filed 31 disclosures in the last 12 months, including 3 insider, 3 5% holder, 2 issuance and 1 contract. The most recent key filing was on Jun 10: Worth 17.2% of last year's revenue, over about 36 months.

Revenue for 2025 was ₩2.6B, up 18% on 2024. It made an operating loss of ₩16.5B. Debt was 38% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩1.3B and operating loss of ₩11B.

The 2025 annual report lists 139 employees with an average tenure of 2.7 years and average pay of ₩58.1M, #1258 of 2,191 listed companies by average pay. Its 9 directors and auditors were paid ₩109.4M each on average. It paid no cash dividend for 2025. 김동현 and related parties held 25.98% at year end.

Of 3 recent 5%+ holder reports, 1 raised and 2 cut a stake; the largest stake reported was 27.46% on Jun 1.

From the 2025 annual report

Staff: 139 (69 men, 70 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩8.1B. Directors and auditors: 9, paid ₩984.8M in total.

No cash dividend was paid for 2025.

Largest shareholder

김동현 holds 15.28%; with 5 related parties the group holds 25.98% of common shares at year end (from 33.25% at the start of the year).

Auditor: 삼도회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

1 new supply contract worth 17% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary

5%+ holder reports